Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan's albuterol
sulfate extended-release 8 mg tablets to Pliva's VoSpire™ ER 8 mg tablets following a single,
oral 8 mg (1 x 8 mg) dose administered under fed conditions.